力生制药
(002393)
| 流通市值：45.63亿 | | | 总市值：46.08亿 |
| 流通股本：1.82亿 | | | 总股本：1.84亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,153,032,801.76 | 911,572,469.8 | 657,494,289.85 | 335,604,291 |
| 营业收入 | 1,153,032,801.76 | 911,572,469.8 | 657,494,289.85 | 335,604,291 |
| 二、营业总成本 | 969,534,718.85 | 760,759,325.92 | 563,854,410.29 | 286,962,183.18 |
| 营业成本 | 468,151,515.56 | 352,756,286.75 | 249,523,699.31 | 131,534,508.4 |
| 税金及附加 | 22,870,009.44 | 17,265,624.54 | 11,999,513.49 | 5,447,800.28 |
| 销售费用 | 318,939,631.79 | 273,173,599.75 | 198,795,077.94 | 101,167,882.82 |
| 管理费用 | 113,608,259.41 | 77,161,647.35 | 55,632,537.75 | 27,203,287.9 |
| 研发费用 | 105,623,758.45 | 77,600,896.18 | 65,652,162.32 | 23,927,742.21 |
| 财务费用 | -59,658,455.8 | -37,198,728.65 | -17,748,580.52 | -2,319,038.43 |
| 其中:利息费用 | 745,827.17 | 490,571.59 | 374,923.24 | 128,620.05 |
| 其中:利息收入 | 60,529,037.97 | 37,776,103.21 | 18,215,583.34 | 2,513,343.24 |
| 加:公允价值变动收益 | 621,769.35 | - | - | - |
| 加:投资收益 | 15,503,334.26 | 12,087,157.65 | 10,561,465.71 | 6,183,164.05 |
| 资产处置收益 | 238,702,576.63 | 238,611,695.27 | 14,739.21 | 14,739.21 |
| 资产减值损失(新) | -29,251,159.1 | - | - | - |
| 信用减值损失(新) | 2,618,628.99 | 305,476.8 | 161,835.19 | 77,593 |
| 其他收益 | 8,112,452.68 | 1,909,094.71 | 560,610.59 | 190,866.69 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 419,805,685.72 | 403,726,568.31 | 104,938,530.26 | 55,108,470.77 |
| 加:营业外收入 | 560,904.07 | 1,352,146.85 | 1,197,442.57 | 1,130,976.99 |
| 减:营业外支出 | 152,258 | 106,940.35 | 101,676.6 | 1,653.63 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 420,214,331.79 | 404,971,774.81 | 106,034,296.23 | 56,237,794.13 |
| 减:所得税费用 | 58,386,341.77 | 62,305,558.63 | 15,852,043.56 | 9,737,457.73 |
| 六、净利润 | 361,827,990.02 | 342,666,216.18 | 90,182,252.67 | 46,500,336.4 |
| 持续经营净利润 | 361,827,990.02 | 342,666,216.18 | 90,182,252.67 | 46,500,336.4 |
| 归属于母公司股东的净利润 | 361,827,990.02 | 342,666,216.18 | 90,182,252.67 | 46,500,336.4 |
| (一)基本每股收益 | 1.97 | 1.86 | 0.49 | 0.25 |
| (二)稀释每股收益 | 1.97 | 1.86 | 0.49 | 0.25 |
| 八、其他综合收益 | 238,666,518.61 | - | - | - |
| 归属于母公司股东的其他综合收益 | 238,666,518.61 | - | - | - |
| 九、综合收益总额 | 600,494,508.63 | 342,666,216.18 | 90,182,252.67 | 46,500,336.4 |
| 归属于母公司股东的综合收益总额 | 600,494,508.63 | 342,666,216.18 | 90,182,252.67 | 46,500,336.4 |
| 公告日期 | 2024-03-22 | 2023-10-30 | 2023-08-25 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |